Gray Cameron 4
4 · Cue Biopharma, Inc. · Filed Jan 6, 2020
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Award
Stock Option (right to buy)
2020-01-02+8,000→ 8,000 totalExercise: $16.31From: 2021-01-02Exp: 2030-01-02→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy.